Delivery Order SPE2DB22D9239-SPE2DB24FDL16

Award Date 7/23/24
Potential Completion Date 8/13/24
Potential Value $80K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $40,109.20, is a firm fixed-price delivery order for Keytruda 100 mg/4 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,131.04 contract is to provide Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $98,449.80 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vial 4 ml, a cancer treatment drug. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This federal contract award, valued at $80,285.70, was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued up to $499,999,999, which runs through December 31, 2025. The contract is for the delivery of Keytruda 100 mg/4 ml vial, a specialized oncology medication, to support the recurring medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $80,218.40, is for the supply of Keytruda 100 mg/4 ml vials, a cancer medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA...
This federal contract award, valued at $81,895.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,379,133 units of Keytruda 100 mg/4 mL vial (4 mL). This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $160,571.40 fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vial with a completion date of July 25, 2024. This order is placed under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's Medical Supply...
This is a $80,285.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,564 vials of the oncology drug Keytruda (100 mg/4 ml) with a completion date of May 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $80,218.40, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,294.20 firm fixed-price delivery order is for the provision of 100 mg/4 mL Keytruda vials to support the recurring medical supply needs of military health facilities. The contract is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDL16
    Delivery Order

This federal contract award, valued at $80,218.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,241,911 units of Keytruda 100 mg/4 ml vial, a biologic medication used in cancer treatment.

This contract is a firm fixed-price delivery order that is not set aside. It is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and specialized medications to the Department of Defense healthcare system.

Generated 10/22/24, 9:09 AM